Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Rosoxacin is a quinolone derivative antibiotic for the treatment of bacterial infection of respiratory tract, urinary tract, GI, CNS and immuno compromised patients. Rosoxacin is known to be effective against... Rosoxacin is known to be effective against penicillin resistant strains and is a single dose orally administered drug, which avoids all complications of parenteral administration seen with penicillin, especially anaphylactic shock.
- Mechanism
- Curator reviewed
Rosoxacin binds to and inhibits the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination.
- Primary indication
- For the treatment of bacterial infection of respiratory tract, urinary tract, GI, CNS and immuno compromised patients.Curator reviewed
- Formula / weight
- C17H14N2O3 · 294.3047 g/mol (avg)
- Also known as
- Acrosoxacin
- Code names
- TO 133 · Win 35213
Resolves to
XBPZXDSZHPDXQU-UHFFFAOYSA-NSMILESCCN1C=C(C(O)=O)C(=O)C2=C1C=C(C=C2)C1=CC=NC=C1What you can answer from here — as of September 12, 2026
Which drugs share a target with Rosoxacin, and which of those have an active Phase 3 trial?